id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-2016-0003,FDA,FDA-2022-E-2016,Letter to U S Patent and Trademark Office,Other,Letter(s),2022-09-13T04:00:00Z,2022,9,2022-09-13T04:00:00Z,,2022-09-13T17:18:02Z,,0,0,09000064852f93d6
FDA-2022-E-2016-0002,FDA,FDA-2022-E-2016,Cover Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-08-25T04:00:00Z,2022,8,2022-08-25T04:00:00Z,,2022-08-25T15:56:42Z,,0,0,0900006485274af3
FDA-2022-E-2016-0001,FDA,FDA-2022-E-2016,"Patent Extension Application from Goodwin Procter LLP on behalf of Kyowa Kirin Co., Ltd.",Other,Application,2022-08-25T04:00:00Z,2022,8,2022-08-25T04:00:00Z,,2022-08-25T15:56:22Z,,0,0,09000064852744a6